19 June 2013
Keywords: azd3480, go, into, ph, iii, cds, testing
Article | 15 December 2008
Anglo-Swedish drug major AstraZeneca and US drug developer Targacept say that top-line results from a Phase IIb trial of AZD3480 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
15 December 2008
18 June 2013
© 2013 thepharmaletter.com